Swiss Drugmakers not Contacted by China after GSK Probe

by swisscham in Engineering, Manufacturing

Swiss drugmakers Novartis and Roche said on Wednesday they were not aware they were under scrutiny by Chinese authorities in light of the ongoing investigation into British drugmaker GlaxoSmithKline on allegations of bribery. “We have not been contacted by Chinese authorities on this matter,” Novartis Chief Executive Joseph Jimenez told reporters on a conference call. Chinese police on Monday accused British drugmaker GlaxoSmithKline of channeling bribes to Chinese officials and doctors through travel agencies to boost sales illegally and raise the price of its medicines in the country. Fellow Swiss drugmaker Roche also said it had not been approached by officials in the country. “We are not aware of any anti-corruption probes in China against Roche. We are committed to ensure the same high standards of compliance for all Roche employees worldwide,” a spokesman said in a statement.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Your Swiss Business Platform in China

SwissCham China has roughly 600 company members. Our Chamber maintains a strong relationship with the Embassy of Switzerland, Switzerland Global Enterprise, Swissnex and Switzerland Tourism. As the representative of the Swiss companies established in China, our goal is to help you to increase your business and visibility, especially amongst the Sino-Swiss business community.

Become A Member

Sign Up For Our Newsletter

  • This field is for validation purposes and should be left unchanged.
July 17, 2023
Published By in Business
July 16, 2023
Published By in Engineering / Manufacturing
July 13, 2023
Published By Consulate General of Switzerland in Guangzhou in Engineering / Manufacturing
July 3, 2023
Published By in Bilateral Relations